HumanN, formerly Neogenis Labs, is a Branded, Direct-to-Consumer growth company. HumanN has built a multi-channel marketing and sales capability for its functional food and nutraceutical products, with the majority of sales going through direct channels. Awareness and sales are powered by extensive…
HumanN, formerly Neogenis Labs, is a Branded, Direct-to-Consumer growth company. HumanN has built a multi-channel marketing and sales capability for its functional food and nutraceutical products, with the majority of sales going through direct channels. Awareness and sales are powered by extensive national media campaigns built around Live Endorsement Radio, TV, and direct mail.
Named to the Austin A-List of the 12 hottest startups, the company has also appeared on the Inc5000 list the past two years running.
As opposed to OTC drugs or most other functional food products, HumanN (pronounced "human") has proprietary IP in the form of 7 US and international patents, with clinical studies to back up product claims and efficacy. Proprietary ingredient and production sourcing in the Supply Chain also contribute to the IP value of the company.
The initial product line was centered on products that help the body generate Nitric Oxide, which promotes cardiovascular health, endurance and energy, along with other quantifiable physiological benefits.
Having built a large customer base with strong repurchase economics, HumanN is poised to increase its growth rates by expanding its product line into additional product categories that appeal to its customer demographic.
Growing 60% YOY and achieving 2016 revenue over $28 million, HumanN is being operated as a growth company, with most free cash flow being reinvested into the business. Gross margins are 80%.
Team (2)
Sectors humanN serves:
Life Sciences
Consumer Goods
Join Axial's Private M&A Platform
humanN connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
